Fundraising FoxBioOra
New Zealand, NZ · 4 known investors
Find your way into BioOra
Sign up to see every warm intro you have to BioOra
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioOra team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.
Investors · 4
How we know: Booster Innovation Fund's portfolio page · Not right? Tell us
How we know: Bridgewest Ventures's portfolio page · funding news · nbr.co.nz · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AOct 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does BioOra do?
- BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.
- Who are BioOra's investors?
- BioOra's investors include Booster Innovation Fund, Bridgewest Ventures, Cure Kids Ventures, Mainland Angel Investors.
- Where is BioOra headquartered?
- BioOra is headquartered in New Zealand, NZ.